Download FREE Report Sample
Download Free sampleInterferons (IFNs) are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and also tumor cells. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.
Interferon Market contains market size and forecasts of Interferon in global, including the following market information:
Global Interferon Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Interferon Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Interferon companies in 2021 (%)
The global Interferon market was valued at 4463.6 million in 2021 and is projected to reach US$ 2727.5 million by 2028, at a CAGR of -6.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Long-lasting Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Interferon include Roche, Anke Biotechnology, Bayer, Merck & Co, Tri-Prime, Kawin, Kexing Pharmaceutical, Novartis and Biogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interferon manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interferon Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Interferon Market Segment Percentages, by Type, 2021 (%)
Long-lasting Type
Ordinary Type
Global Interferon Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Interferon Market Segment Percentages, by Application, 2021 (%)
Hepatitis
Multiple Sclerosis
Others
Global Interferon Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Interferon Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interferon revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Interferon revenues share in global market, 2021 (%)
Key companies Interferon sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Interferon sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Anke Biotechnology
Bayer
Merck & Co
Tri-Prime
Kawin
Kexing Pharmaceutical
Novartis
Biogen
Merck KGaA
Zydus Cadila
Huaxin Biotechnology
Harbin Pharmaceutical
Xiamen Amoytop Biotech
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy